Evolution of the Average Target: Kenvue Inc.

Evolution of the Target Price: Kenvue Inc.

Changes in Analyst Recommendations: Kenvue Inc.

bbc.Aioa6W_lLYhnSVj9RtOHS4AYbL3DOkSj-xVsbTwcIdk.U0h30ReWGcFUKAvJDKbxAOVqHfPwAgfIzFY-Omktaa9AdSqELr1czg0hMw~683c83ebb3db898c8a0b3a19e46af531
Nov. 11 BNP Paribas Exane Adjusts Price Target on Kenvue to $19 From $21, Maintains Neutral Rating MT
Nov. 07 Barclays Adjusts Price Target on Kenvue to $18 From $17, Maintains Equalweight Rating MT
Nov. 04 Deutsche Bank Adjusts Kenvue Price Target to $19 From $18, Maintains Hold Rating MT
Nov. 04 Deutsche Bank Adjusts Price Target on Kenvue to $19 From $18, Maintains Hold Rating MT
Nov. 04 Canaccord Genuity Adjusts Price Target on Kenvue to $17 From $15, Maintains Hold Rating MT
Nov. 04 HSBC Adjusts Price Target on Kenvue to $17 From $19, Maintains Hold Rating MT
Nov. 04 RBC Lowers Price Target on Kenvue to $21 From $22, Keeps Sector Perform Rating MT
Nov. 04 MORNING BID AMERICAS-Nerves rising about frothy valuations RE
Nov. 03 Citigroup Adjusts Price Target on Kenvue to $18 From $17 MT
Nov. 03 Kenvue says measured brand trust in Tylenol remain at same level as early September RE
Oct. 29 Canaccord Genuity Downgrades Kenvue to Hold From Buy, Adjusts Price Target to $15 From $26 MT
Oct. 27 Jefferies Adjusts Price Target on Kenvue to $23 From $25, Maintains Buy Rating MT
Oct. 23 Deutsche Bank Adjusts Price Target on Kenvue to $18 From $20, Maintains Hold Rating MT
Oct. 10 JPMorgan Adjusts Price Target on Kenvue to $21 From $24, Maintains Overweight Rating MT
Oct. 08 UBS Adjusts Kenvue Price Target to $17 From $23, Maintains Neutral Rating MT
Oct. 08 Citigroup Adjusts Price Target on Kenvue to $17 From $20, Maintains Neutral Rating MT
Oct. 06 BofA Bullish on Publicis on Potential Q3 Beat, Healthcare Wins MT
Oct. 01 Goldman Sachs Adjusts Price Target on Kenvue to $19 From $22, Maintains Neutral Rating MT
Sep. 30 Barclays Adjusts Price Target on Kenvue to $17 From $20, Maintains Equalweight Rating MT
Sep. 26 Rothschild & Co Redburn Upgrades Kenvue to Buy From Neutral, Adjusts Price Target to $22 From $22.50 MT
Sep. 26 Analyst recommendations: Carmax, American Airlines, Applovin, Pure Storage… Zonebourse
Sep. 23 Kenvue rose as Trump Tylenol claims add nothing new, strategist says RE
Sep. 23 Sector Update: Health Care Stocks Edge Higher Late Afternoon MT
Sep. 23 Sector Update: Health Care Stocks Advance Tuesday Afternoon MT
Sep. 23 Evercore ISI Adjusts Price Target on Kenvue to $18 From $23, Maintains In Line Rating MT
More recommendations

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+12.34%
+16.1%
+10.57%
+9.8%
+1.73%
+23.63%
+8.7%
+14.27%
+9.19%
Average +11.82%
Weighted average by Cap. +13.32%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
17.21USD
Average target price
19.33USD
Spread / Average Target
+12.34%
High Price Target
23.00USD
Spread / Highest target
+33.64%
Low Price Target
17.00USD
Spread / Lowest Target
-1.22%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BNP Paribas Exane
Barclays
Deutsche Bank Securities
Canaccord Genuity
HSBC
RBC Capital Markets
Citigroup
Jefferies & Co.
JPMorgan Chase
UBS
Goldman Sachs
Rothschild & Co Redburn
Evercore ISI
Piper Sandler
Redburn Atlantic
Wells Fargo Securities
Bernstein
William Blair & Co.
Argus
Edward Jones
BofA Securities
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
17.21USD
Average target price
19.33USD
Spread / Average Target
+12.34%
Consensus

Quarterly revenue - Rate of surprise